Stempeucel-DFU

Stempeutics out licenses its novel stem cell product “Stempeucel-DFU” to Cipla for treating non healing Diabetic Foot Ulcer (DFU)

Diabetic foot is one of the most significant and devastating complications of diabetes Out of approx. 70 million diabetics in India,…

5 years ago